Home › Research › How common it is
Global Prevalence of Young-Onset Dementia: A Systematic Review and Meta-analysis
Hendriks S, Peetoom K, Bakker C, et al. (Young-Onset Dementia Epidemiology Study Group). JAMA Neurology, 2021-09
Topic: Risk, prevention and care in population studies
Plain-language summary
This large meta-analysis pooled dozens of studies to estimate how many people under age 65 are living with dementia worldwide. The researchers found roughly 3.9 million people globally have young-onset dementia, roughly double earlier estimates, with rates climbing steeply from the early 30s to the early 60s. It highlights a group of patients who are often missed or misdiagnosed because dementia is usually thought of as a disease of old age.
What this study adds
Evidence grade: Moderate
This is a pooled review of 2,760,379 participants. Roughly 3.9 million people worldwide under age 65 are living with young-onset dementia, about double earlier estimates, with rates climbing steeply from the early 30s to the early 60s. Its stated limit: Substantial heterogeneity existed across the pooled studies in case-ascertainment methods and diagnostic criteria, and most underlying studies came from high-income countries, limiting generalizability to low- and middle-income settings.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Hendriks, S., Peetoom, K., Bakker, C., et al. (2021). Global Prevalence of Young-Onset Dementia: A Systematic Review and Meta-analysis. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2021.2161
Vancouver
Hendriks S, Peetoom K, Bakker C, et al. Global Prevalence of Young-Onset Dementia: A Systematic Review and Meta-analysis. JAMA Neurology. 2021. doi:10.1001/jamaneurol.2021.2161. PMID: 34279544.
BibTeX
@article{hendriks2021-4479c0b0,
author = {Hendriks, S. and Peetoom, K. and Bakker, C. and others},
title = {{Global Prevalence of Young-Onset Dementia: A Systematic Review and Meta-analysis}},
journal = {JAMA Neurology},
year = {2021},
doi = {10.1001/jamaneurol.2021.2161},
pmid = {34279544},
url = {https://doi.org/10.1001/jamaneurol.2021.2161}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Global age-standardized prevalence of young-onset dementia (ages 30-64) was 119.0 per 100,000 population
- Estimated 3.9 million people worldwide are living with young-onset dementia
- Prevalence rose sharply with age within the young-onset range, from 1.1 per 100,000 (ages 30-34) to 77.4 per 100,000 (ages 60-64)
- Estimate is roughly double prior widely cited prevalence figures for young-onset dementia
Why it matters
Roughly 3.9 million people worldwide under age 65 are living with young-onset dementia, about double earlier estimates, with rates climbing steeply from the early 30s to the early 60s. This highlights a group of patients often missed or misdiagnosed because dementia is usually thought of as a disease of old age.
New to this subject? Start with our plain-English guide: Alzheimer's in numbers →
Study details
- Study designmeta-analysis
- Participants2,760,379
- Effect sizeAge-standardized prevalence of 119.0 per 100,000 population aged 30-64, equating to an estimated 3.9 million people worldwide living with young-onset dementia; prevalence increased from 1.1 per 100,000 (ages 30-34) to 77.4 per 100,000 (ages 60-64)
- Evidence strengthModerate
Limitations
Substantial heterogeneity existed across the pooled studies in case-ascertainment methods and diagnostic criteria, and most underlying studies came from high-income countries, limiting generalizability to low- and middle-income settings.
How this study scored 77/100
Published in a leading specialty journal, and it is a meta-analysis pooling many studies. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 48 of the 62 points we could judge it on, which is 77 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (JAMA Neurology) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 12 / 12 | A meta-analysis pooling many studies |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2021 — within 6 year(s) of the newest study here |
| Sample size | 4 / 4 | 2,760,379 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 34279544) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 48 / 62 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 48 of the 62 points we could judge it on is 77 out of 100. |
| Total | 77 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 24.
Later studies that cite this one
31 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in How common it is from nearby years
Also tagged “prevalence”
1,225 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,225 tagged studies.